BACHEM INC

Overview

BACHEM INC is an active pharmaceutical ingredient (API) supplier with 21 active FDA Type II Drug Master Files, covering 5-AMINOLEVULINIC ACID HYDROCHLORIDE; BIVALIRUDIN; CARBIDOPA; ETOMIDATE; GLUCAGON; GLUCAGON PHARMA GRADE.

API / Drug Master Files

BACHEM INC holds 21 active (47 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• GOSERELIN ACETATEActive2024-05-07
• OCTREOTIDE HYDROCHLORIDEActive2023-10-23
• SEMAGLUTIDEActive2023-03-16
• GONADORELIN ACETATEActive2020-11-26
• GOSERELIN ACETATEActive2019-12-19
• ZP4207Active2019-11-21
• OCTREOTIDE ACETATEActive2019-09-27
• GLUCAGON PHARMA GRADEActive2018-06-08
• BIVALIRUDINActive2017-03-31
• LIRAGLUTIDE DRUG SUBSTANCEActive2016-06-29
• TETRACOSACTIDEActive2014-11-26
• ICATIBANT ACETATEActive2007-09-17
• ETOMIDATEActive2007-01-29
• GLUCAGONActive2005-04-12
• HISTRELIN ACETATEActive2003-10-30

Showing 15 of 47 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BACHEM INC in our records. PharmaTek screens the full directory against live FDA enforcement data.